E-Qure Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EQUR research report →
Price Chart
About the company
E-Qure Corp. , a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery.
- CEO
- Ohad Goren
- IPO
- 1994
- Employees
- 1
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on EQUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.91K
- P/E
- -0.01
- PEG
- 0.00
- P/S
- 0.00
- P/B
- -0.02
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 175.41%
- ROIC
- 262.00%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-647,661
- Net Income
- $-577,051-30.0%
- EPS
- $-0.02-30.5%
- OCF Growth
- +21.4%
- FCF Growth
- +21.4%
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 1.15
- RSI (14)
- 6
- Avg Volume
- 286
No earnings-call transcripts are available for EQUR yet.
- Free Float
- 77.7%
- Shares Outstanding
- 34.55M
- Float Shares
- 26.86M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 14 | WEISSBERG RON | sell | 62,380 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EQUR coverage
Recent articles, reports, and earnings notes.
No research on EQUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EQUR report →Enovis (NYSE:ENOV) vs. ADB International Group (OTCMKTS:EQUR) Financial Comparison
defenseworld.net · Aug 9
Head-To-Head Review: Waters (NYSE:WAT) and ADB International Group (OTCMKTS:EQUR)
defenseworld.net · Mar 26
Contrasting Delcath Systems (NASDAQ:DCTH) & ADB International Group (OTCMKTS:EQUR)
defenseworld.net · Mar 23
Analyzing ADB International Group (OTCMKTS:EQUR) & Neuronetics (NASDAQ:STIM)
defenseworld.net · Mar 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.